Market Cap
$89.09 Billion
USD as of Jan. 1, 2024
Company | Market Cap (USD) |
---|---|
MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
Takeda Pharmaceutical Company Limited | $47.71 B |
Haleon plc | $38.90 B |
PPD, Inc. | $16.58 B |
Eisai Co. Ltd | $14.86 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Zoetis Inc. is a pharmaceutical company particularly engaged in treatments for pets and livestock. It researches, develops, manufactures, and markets medicine, vaccines, and diagnostic products, as well as biodevices, genetic tests, services, and animal health solutions for pets and companion animals, farm animals, and precision livestock farming.
Zoetis Inc. has the following listings and related stock indices.
Stock: NYSE: ZTS
Stock: BMV: ZTS
Stock: Bovespa: Z1TS34
Stock: XETR: ZOE
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.